Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease.
Ontology highlight
ABSTRACT: The A/T/N research framework has been proposed for the diagnosis and prognosis of Alzheimer's disease (AD). However, the spatial distribution of ATN biomarkers and their relationship with cognitive impairment and neuropsychiatric symptoms (NPS) need further clarification in patients with AD. We scanned 83 AD patients and 38 cognitively normal controls who independently completed the mini-mental state examination and Neuropsychiatric Inventory scales. Tau, Aβ, and hypometabolism spatial patterns were characterized using Statistical Parametric Mapping together with [18F]flortaucipir, [18F]florbetapir, and [18F]FDG positron emission tomography. Piecewise linear regression, two-sample t-tests, and support vector machine algorithms were used to explore the relationship between tau, Aβ, and hypo
SUBMITTER: Dang M
PROVIDER: S-EPMC9842886 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA